ALYSSA PERCHINSKE: Open Payments
NPI 1588335988 · BEACHWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$185 in 11 payments from 8 companies in 2025. Trend: 2023 $86 · 2024 $305 · 2025 $185
Food & beverage: $185
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $36 |
| Novo Nordisk Inc | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 2 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: OTEZLA, XIFAXAN, MOUNJARO, ULTOMIRIS, VOQUEZNA, SHINGRIX, AIRSUPRA.
Industry payments across OH — which companies pay providers there.
